RxDoctor Payments DataLook up a doctor →

Steven Coutre

Hematology · Palo Alto, CANPI 1073600441

Payments from drug & device makers

$7,018,373in general payments, 2019–2025

Across 409 payments — averaging $17,160 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4.9M
  • Acerta Pharma LLC$695K
  • Janssen Research & Development, LLC$613K
  • Pharmacyclics LLC, An Abbvie Company$601K
  • Gilead$66K
  • Beigene AUS Pty Ltd$35K
  • plus $96K from 14 others
$215,257in research payments, 2019–2025

Across 16 payments — averaging $13,454 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$213K
  • Pharmacyclics LLC, An Abbvie Company$2K

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,018,373 in reported general payments places this provider in the 90th percentile of 178 hematology providers in California.

See all hematology providers in California

Other hematology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →